Enable Biosciences Inc.

About Enable Biosciences Inc.

Enable Biosciences is a company focused on creating the next generation of tools for predictive medicine. Spun out of UC Berkeley and Stanford in 2016, they collaborate with institutions like Stanford Healthcare, Harvard Medical School, and JDRF. With over 150,000 tests performed, their mission is to enable the future of healthcare through innovative testing and technology.

Products & Services

Type 1 Diabetes Testing:Best-in-class autoantibody tests for early detection and risk prediction of Type 1 Diabetes using ADAP technology.

Kit to Clinics:A service launching rigorously vetted ADAP technology for diabetes care.

Specialties

Predictive Medicine Type 1 Diabetes Testing Autoantibody Detection ADAP Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Phase IIB SBIR T: - FT: Phase IIB SBIR	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2023-12-19 FD: 2023-12-19	1 investors

Phase IIB SBIR Latest

2023-12-19

$3.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Monica Embers

Ph.D.

K

Kari Nadeau

Director of the Sean N. Parker Center for Allergy and Asthma Research and Endowed Professor at Stanford University

P

PJ Utz

Professor

D

Desmond Schatz

Professor and Associate Chairman of Pediatrics, Medical Director of the Diabetes Center and Associate Director of the GCRC

B

Bruce Buckingham

Professor of Pediatrics in Endocrinology and Diabetes

D

David Maahs

Professor of Pediatrics and Division Chief of Pediatric Endocrinology and co-director of the Stanford Diabetes Research Center

View 24 more team members with Pro

Unlock Full Team Directory

Recent News